Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?

J Thromb Haemost. 2019 Jan;17(1):3-5. doi: 10.1111/jth.14331. Epub 2018 Dec 10.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Gastrointestinal Microbiome*
  • Humans
  • Methylamines
  • Microbiota*
  • Platelet Aggregation
  • Thrombosis*

Substances

  • Methylamines
  • trimethyloxamine